GlaxoSmithKline (GSK) Seeking Buyer for European Non-Core Drugs Portfolio -IBT
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Join SI Premium – FREE
According to International Business Times, GlaxoSmithKline (NYSE: GSK) has resumed its search to find a buyer for the company's European non-core drugs portfolio. A source has said final bid are due Wednesday. Sanofi (NYSE: SNY), Advent International and Avista could be possible suitors for the unit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Holcim said to acquire part of James Hardie's EU business
- Vireo Growth completes acquisition of C21 Investments
Create E-mail Alert Related Categories
Mergers and Acquisitions, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
